The Consumer Voice on Twitter: "Congrats @Altroconsumo for winning the #Avastin #Lucentis case! Your hard-won fight is a victory for consumers. Reminder: Roche & Novartis were accused of secretly agreeing to restrict
Lucentis (ranibizumab) for the Treatment of Diabetic Macular Edema (DME) - Clinical Trials Arena
Roche looks to delivery device to keep Lucentis biosimilars at bay - BioProcess InternationalBioProcess International
Dosing & Administration for wAMD | LUCENTIS® (ranibizumab)
Lucentis: Package Insert / Prescribing Information - Drugs.com
Roche's Diabetic Retinopathy Drug Lucentis Gains FDA “Priority Review”
Paid to Promote Eye Drug, and Prescribing It Widely - The New York Times
Lucentis Backed by FDA Pannel for Extended Approval